[Antinatriuretic effect of sulfinpyrazone].

Author: HäuselmannH J, StuderH

Paper Details 
Original Abstract of the Article :
Clinical observations suggest that sulfinpyrazone (Anturan) may lead to edema formation in borderline compensated cardiac insufficiency. Since the drug is increasingly used in secondary prophylaxis of sudden death after myocardial infarction, a trial was designed to confirm or to refute the suspicio...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/7268356

データ提供:米国国立医学図書館(NLM)

The Antinatriuretic Effects of Sulfinpyrazone

This research delves into the fascinating world of [pharmacology] and its impact on the delicate balance of [fluid balance]. The study focused on sulfinpyrazone (Anturan), a drug commonly used to prevent [sudden death after myocardial infarction]. The authors employed a [controlled trial] to investigate whether sulfinpyrazone could disrupt [natriuresis], a critical process that regulates [sodium excretion]. Their findings revealed that sulfinpyrazone indeed interfered with [sodium excretion], leading to a potential risk for individuals with [borderline compensated cardiac insufficiency]. The design of the trial provides a valuable framework for studying the clinically relevant [antinatriuretic side effects] of many drugs, especially those used in [non-steroidal antiinflammatory agents].

Sulfinpyrazone's Antinatriuretic Effect

The research unveiled the remarkable [antinatriuretic effect] of sulfinpyrazone. The study demonstrated a significant reduction in [sodium excretion] in participants given sulfinpyrazone, compared to those who did not receive it. These findings, particularly the significant [p less than 0.05] value, are compelling evidence of sulfinpyrazone's influence on [natriuresis].

Implications for Patients with Cardiac Insufficiency

These findings underscore the importance of considering the potential [antinatriuretic effect] of sulfinpyrazone, especially for patients with [borderline compensated myocardial insufficiency]. It is crucial to understand how medications can influence [fluid balance] and its potential consequences for individuals with [cardiac insufficiency]. These insights highlight the need for cautious medication management, especially for patients with pre-existing [cardiac conditions].

Dr. Camel's Conclusion

This study is like a desert oasis, providing crucial information about the [antinatriuretic effect] of sulfinpyrazone. It is essential to remember that even a seemingly harmless drug can have significant [side effects] and that a thorough understanding of [pharmacology] is crucial for effective patient care. Just as a desert traveler must carefully manage their water supply, so too must we carefully consider the potential effects of medications on our body's delicate [fluid balance].

Date :
  1. Date Completed 1981-10-14
  2. Date Revised 2013-11-21
Further Info :

Pubmed ID

7268356

DOI: Digital Object Identifier

7268356

Related Literature

SNS
PICO Info
in preparation
Languages

German

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.